Sign In

Anupama Rao Singh

Latin America| Global Oncology Innovative Assets | Global Marketing & Commercialization | Transforming Cancer Care| Economic Times Women Ahead 2023 | Harvard Business School

Anupama Rao Singh is a prominent business leader in the pharmaceutical industry, currently holding several key positions at Dr. Reddy's Laboratories. She serves as the Vice President and LATAM Region Head, as well as leading the Oncology EM COE and Global Oncology Innovative Assets COE.14

Professional Achievements

Anupama has been recognized for her leadership and contributions to the industry:

  • Winner of the Economic Times Women Ahead 2023 award1
  • Finalist for the WeQual Awards APAC 20247

Educational Background

Anupama has pursued executive education to enhance her leadership skills:

  • Completed an executive education course on managing innovation at Harvard Business School's Boston Campus3

Areas of Expertise

Global Business Leadership:: Anupama is known for her role in global business and P&L leadership, particularly in the Latin American market.14

Oncology and Innovation:: Her work focuses on oncology and innovative assets in the pharmaceutical sector, demonstrating a commitment to advancing healthcare solutions.12

Market Access Strategies:: Anupama engages in discussions about advancements in Market Access and strategic planning within the industry.2

Recent Accomplishments

In November 2024, Anupama and her team in Latin America achieved a significant milestone, which was celebrated by colleagues and industry professionals.4

Personal Interests

Beyond her professional pursuits, Anupama shows an interest in:

  • Fitness and health6
  • Innovation and leadership strategies5

Anupama Rao Singh's career trajectory and accomplishments position her as a respected figure in the global pharmaceutical industry, with a particular focus on oncology and emerging markets.

Highlights

Aug 22 · linkedin

Can Entrepreneurship be Institutionalized? One of the common themes across my career journey is the joy of “Building” or “Creating” things from ground up – whether its building new brands/digital solutions, go to market strategies for new therapeutic areas, opening new countries/new regions /new business models. A lot of this has been within the realms of large/established corporations

I was intrigued by a question of Intrapreneur vs Entrepreneur as part of interesting chat show at Dr.Reddy’s called the Leader’s POV. Attached is a clip of what I shared as a response.

There are many learnings in setting up a new venture/innovation inside a large corporation. Here are my top 3 :

  1. Mothership Advantage: A new venture in a large corporation does get the mothership (core business) advantage of resources, talent, investments and existing brand image that can give the new venture a headstart. With right resourcing, focus and time invested, the mothership can truly be an advantage for a new venture.

  2. Proximity to the core: This can be a double edged sword. Every large corporation has a core business that brings majority of revenues for the company (>60%). New ventures/Initiatives are usually closer to or farther from core business.

    -->Closer to core: Good to leverage existing customer connects/systems/processes and talent -->Farther from core: Good to build new systems/processes/talent however have resourcing cord to core by design almost like osmosis. The new venture could open new doors for existing business and vice versa.

    -->Depending on the proximity, governance mechanisms should be evolved for the new venture. One pitfall to be avoided is the constant comparison to existing core business performance.

  3. Leadership: The leadership team of the new venture in a large corporation has a particularly tough and a dual role. It is not only to set up the new venture but also being the evangelist of the new venture in the existing system which involves educating, enlisting stakeholders, overcoming inertia/resistance of large corporation workings, pushing the boundaries of the system and make it relevant for the new venture, pivoting strategy if need be !

This quote from an HBS article beautifully sums it up - To deal with “uncertain” terrains, you need “certain” processes* (*Ref: Institutionalized Entrepreneurship : Flagship pioneering, HBS case study, April 2018)

#innovation #leadership #strategy #drreddys #entrepreneurship #healthcare #pharma #marketing Leader's POV video Concept credit Boris Gomes Video Edit credit :Surbhi Nagari

Jun 3 · linkedin

June is always an exciting time with cutting edge advances for cancer care being shared at ASCO Annual meeting. We are excited to have Global and EM experts come together to discuss the unmet needs in the rare cancer type like nasopharyngeal carcinoma and the advances in treatment with role of PD1/PDL1 Inhibitors. As we work towards bringing access to innovative medicines for cancer across India and Emerging markets, we look forward to working with our customers and partners to accelerate this journey! Chitra Ranade Ram Murali kaveri khanna Rohit R Desai Derica Serra , MD

https://lnkd.in/gnWXwx_4

#ASCO2024 #oncology #pharma #drreddys #goodhealthcantwait #BRICS #cancer #immunoncology #PDL1 #checkpointinhibitors

Related Questions

What are some of Anupama Rao Singh's key achievements at Dr. Reddy's Laboratories?
How did Anupama Rao Singh become the Vice President of the LATAM Region at Dr. Reddy's Laboratories?
What strategies has Anupama Rao Singh implemented in the LATAM region for oncology?
What is the Global Oncology Innovative Assets COE at Dr. Reddy's Laboratories?
How has Anupama Rao Singh's leadership style impacted Dr. Reddy's Laboratories?
Anupama Rao Singh
Anupama Rao Singh, photo 1
Anupama Rao Singh, photo 2
Add to my network

Location

Hyderabad, Telangana, India